RE: Is this Share Considered a good ROI?13 Aug 2022 13:45
Obviously no need to pump here, just let the good news continue to flow for the rest of the month.
£1.3m upfront payment for the sale of CD4 test. A further payment of upto £4m after Kenya studies. Plus a further royalty payment of upto £1m.
Plus ODX have stopped loosing £500,000 a month
by the sale of Alva site and the selling of CD4 test.
Now Concentrating on Health and Nutrition business which had increased sales from £6.8m - £8.6m within the year.
This is alot better than a few months back when loosing money after increasing capacity for the government.
Concentrating on H and N sales with funds available, will surely increase growth further.
Directors setting an average of 12p or greater for 90 days requirement.
£2.5m government pre production payment dispute news must be soon. Even if this has to paid back, as said before maybe over 24 months at approx £100,000 a month would be achievable if increasing H and N sales.
Im gonna bet
3.35 Newbury Chindit